Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aloe vera gel is a topical botanical preparation derived from the *Aloe vera* plant, utilized for its immunomodulatory, anti-inflammatory, antioxidant, and wound-healing properties. In clinical research conducted by The Oxford Dental College, Hospital and Research Center in Bangalore, India, it has been investigated as a treatment for oral submucous fibrosis (OSMF), a chronic condition often caused by areca nut use that carries a high risk of malignancy. The therapeutic regimen evaluated in Phase 3 trials typically involves the topical application of the gel to oral lesions (approximately 5mg per application) in combination with the oral ingestion of aloe vera juice (30ml twice daily). The preparation aims to alleviate symptoms such as burning sensations and to improve oral mobility, including mouth opening, cheek flexibility, and tongue protrusion, by targeting inflammatory and oxidative pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aloe vera gel (Oxford Dental College).